Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS gets equipment worth R3,9 million to do doping tests for the World Cup
2010-05-18

One of the new state-of-the-art machines to be used for dope testing.
Photo: Mangaliso Radebe


The South African Doping Control Laboratory (SADoCoL) at the University of the Free State (UFS) in Bloemfontein boasts new state-of-the-art equipment worth R3,9 million with which doping tests for next month’s 2010 FIFA World Cup will be done.

“Our new instruments are some of the best in the world,” said a proud Dr Pieter van der Merwe, Head of the laboratory.

SADoCoL, housed in the Department of Pharmacology at the UFS, has done doping analyses for many international sport events in South Africa and elsewhere in the world, including the 1995 Rugby World Cup and the Sevens Rugby World Cup in Dubai.

“Because of our international recognition and accreditation by the World Anti-Doping Agency (WADA) the laboratory was selected to be the official doping control facility of the 2010 FIFA World Cup,” he said.

“FIFA has entered into a contract with us and they will send all the urine and blood samples for the World Cup to this laboratory. I must hasten to say that it is not only for the World Cup. We will continue with the work that we have been doing all these years regarding doping analysis in South Africa.”

“It is an honour for the Department and the UFS to offer a world-class service to a world-class association like FIFA and to be associated with a tournament of this magnitude.”

Being the only one of its kind in South Africa, and one of only two in Africa (the other being in Tunisia), it is not surprising that FIFA has entered into this partnership with SADoCoL.

“It is a well-known fact that we have been, and still are, the official doping control testing facility in South Africa for many years now. So there is also a lot of African involvement in our laboratory where African countries send samples to us for analysis,” he said.

It is not for the first time, though, that SADoCoL is involved with FIFA. The laboratory did all the testing for the Confederations Cup that was held in South Africa in June 2009.

It had just been extended to accommodate the new equipment. An official viewing session of the new facility was held last week.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
18 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept